These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14734797)

  • 1. Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors.
    Cleary MP; Juneja SC; Phillips FC; Hu X; Grande JP; Maihle NJ
    Exp Biol Med (Maywood); 2004 Feb; 229(2):182-93. PubMed ID: 14734797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors.
    Cleary MP; Phillips FC; Getzin SC; Jacobson TL; Jacobson MK; Christensen TA; Juneja SC; Grande JP; Maihle NJ
    Breast Cancer Res Treat; 2003 Feb; 77(3):205-15. PubMed ID: 12602920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.
    Zheng Q; Dunlap SM; Zhu J; Downs-Kelly E; Rich J; Hursting SD; Berger NA; Reizes O
    Endocr Relat Cancer; 2011 Aug; 18(4):491-503. PubMed ID: 21636700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development.
    Hu X; Juneja SC; Maihle NJ; Cleary MP
    J Natl Cancer Inst; 2002 Nov; 94(22):1704-11. PubMed ID: 12441326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice.
    Dogan S; Hu X; Zhang Y; Maihle NJ; Grande JP; Cleary MP
    Breast Cancer Res; 2007; 9(6):R91. PubMed ID: 18162139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors.
    Zheng Q; Hursting SD; Reizes O
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1607-12. PubMed ID: 22692856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEPTIN RECEPTORS EXPRESSION IN MAMMARY TUMORS AND MAMMARY FAT PAD OF TRANSGENIC MAMMARY CANCER MOUSE MODEL.
    Yilmaz E; Thomas P; Tuna B; Cleary M; Dogan S
    Exp Oncol; 2022 Dec; 44(4):272-280. PubMed ID: 36811542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
    Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
    Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.
    Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG; Eitzman DT
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):70-6. PubMed ID: 17095713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-induced obesity and mammary tumor development in MMTV-neu female mice.
    Cleary MP; Grande JP; Juneja SC; Maihle NJ
    Nutr Cancer; 2004; 50(2):174-80. PubMed ID: 15623464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice.
    Chua SC; Liu SM; Li Q; Sun A; DeNino WF; Heymsfield SB; Guo XE
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E384-92. PubMed ID: 14600075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
    Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
    Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
    Nørgaard P; Law B; Joseph H; Page DL; Shyr Y; Mays D; Pietenpol JA; Kohl NE; Oliff A; Coffey RJ; Poulsen HS; Moses HL
    Clin Cancer Res; 1999 Jan; 5(1):35-42. PubMed ID: 9918200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
    Hodgson MC; Vanostran G; Alghamdi S; Poppiti RJ; Agoulnik AI; Agoulnik IU
    PLoS One; 2013; 8(4):e60455. PubMed ID: 23593223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9-mediated generation of obese and diabetic mouse models.
    Roh JI; Lee J; Park SU; Kang YS; Lee J; Oh AR; Choi DJ; Cha JY; Lee HW
    Exp Anim; 2018 May; 67(2):229-237. PubMed ID: 29343656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compound heterozygous leptin receptor mutation causes more severe obesity than in Lepr
    Berger C; Heyne HO; Heiland T; Dommel S; Höfling C; Guiu-Jurado E; Lorenz J; Roßner S; Dannemann M; Kelso J; Kovacs P; Blüher M; Klöting N
    J Lipid Res; 2021; 62():100105. PubMed ID: 34390703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene.
    Kowalski TJ; Liu SM; Leibel RL; Chua SC
    Diabetes; 2001 Feb; 50(2):425-35. PubMed ID: 11272157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enriched environment inhibits breast cancer progression in obese models with intact leptin signaling.
    Foglesong GD; Queen NJ; Huang W; Widstrom KJ; Cao L
    Endocr Relat Cancer; 2019 May; 26(5):483-495. PubMed ID: 30856610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-alpha mice.
    Cleary MP; Grande JP; Maihle NJ
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):956-62. PubMed ID: 15254485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.